What is Pharmright?
Pharmright operates at the intersection of digital health and patient wellness through its flagship LiviPod system. The platform provides a sophisticated, modular architecture designed to monitor, remind, and dispense medications and supplements with precision. By eliminating the need for recurring subscription fees, the company differentiates itself in a crowded market, offering a user-centric approach that empowers individuals and caregivers alike. The integration of real-time alerts and a seamless mobile application interface ensures that Pharmright remains a critical tool for improving health outcomes and simplifying complex medication regimens for diverse user demographics.
How much funding has Pharmright raised?
Pharmright has raised a total of $3M across 3 funding rounds:
Private Equity
$902K
Series A
$1.2M
Private Equity
$865K
Private Equity (2014): $902K, investors not publicly disclosed
Series A (2015): $1.2M led by Upstate Carolina Angel Network and SCRA
Private Equity (2016): $865K, investors not publicly disclosed
Key Investors in Pharmright
Upstate Carolina Angel Network
A member-led angel investment group that provides early-stage capital and strategic mentorship to high-growth startups in the Southeast region.
SCRA
A public, non-profit corporation dedicated to fueling South Carolina's innovation economy by providing funding and support for technology-based startups and academic research.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Pharmright?
With this major enterprise-level funding, Pharmright is positioned to accelerate its product development roadmap and expand its market reach. The strategic allocation of this capital will likely focus on enhancing the LiviPod ecosystem, potentially integrating advanced analytics or expanding compatibility with broader telehealth infrastructures. As the company transitions from its initial scaling phase into a more mature enterprise model, the focus will remain on optimizing supply chain efficiencies and deepening its footprint in the home-health technology landscape, ensuring that its medication management solutions remain at the forefront of the industry.
See full Pharmright company page
